Overview

Interaction Between ABT-335, Rosuvastatin and Warfarin

Status:
Completed
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This is a multiple-dose, double-blind, randomized, single-center, parallel-group study in adult male subjects in general good health.
Phase:
Phase 1
Details
Lead Sponsor:
AstraZeneca
Treatments:
Fenofibrate
Fenofibric acid
Rosuvastatin Calcium
Warfarin